Variable of interest | Reintervention (n = 33) | Chemotherapy (n = 84) | Statistical test | p value |
---|---|---|---|---|
Age (years) | MW-U | 0.085 | ||
Mean | 52.91 | 57.70 | ||
Median | 55.00 | 58.00 | ||
Range | 7–70 | 31–76 | ||
Sex | χ2 | 0.364 | ||
Male | 17 (51.5%) | 51 (60.7%) | ||
Female | 16 (48.5%) | 33 (39.3%) | ||
Comorbidities | χ2 | 0.351 | ||
Present | 7 (21.2%) | 25 (29.8%) | ||
Absent | 26 (78.8%) | 59 (70.2%) | ||
Volume (cm3) | MW-U | 0.501 | ||
Mean | 30.61 | 33.52 | ||
Median | 22.90 | 24.10 | ||
Range | 1.0–111.9 | 1.6–116.5 | ||
Resection at first surgery | χ2 | 0.036 | ||
GTR | 29 (87.9%) | |||
STR | 4 (12.1%) | |||
Surgical assistants | χ2 | 0.415 | ||
None | 11 (33.3%) | 15 (17.9%) | ||
Navigation | 12 (36.4%) | 30 (35.7%) | ||
Advanced | 10 (30.3%) | 39 (46.4%) | ||
IDH status | χ2 | 0.922 | ||
IDH-wildtype | 16 (48.5%) | 44 (52.4%) | ||
IDH-mutant | 1 (3.0%) | 2 (2.4%) | ||
Not studied | 16 (48.5%) | 38 (45.2%) | ||
Complications at first surgery | χ2 | 0.676 | ||
None | 26 (78.8%) | 61 (72.6%) | ||
Grade I | 4 (12.1%) | 15 (17.8%) | ||
Grade II | 2 (6.1%) | 4 (4.8%) | ||
Grade III | 1 (3.0%) | 4 (4.8%) | ||
Grade IV | 0 (0.0%) | 0 (0.0%) | ||
ECOG 1 | χ2 | 0.295 | ||
Asymptomatic/mild | 30 (90.9%) | 70 (83.3%) | ||
Symptomatic | 3 (9.1%) | 14 (16.7%) | ||
Chemotherapy (TMZ) | χ2 | 0.001 | ||
Complete Stupp | 28 (84.8%) | 40 (47.6%) | ||
Incomplete Stupp | 5 (15.2%) | 44 (52.4%) | ||
Progression | χ2 | 0.020 | ||
Only radiological | 24 (72.7%) | 31 (36.9%) | ||
Clinical | 9 (27.3%) | 53 (63.1%) | ||
ECOG 2 | χ2 | 0.001 | ||
Asymptomatic/mild | 27 (81.8%) | 45 (53.6%) | ||
Symptomatic | 6 (18.2%) | 39 (46.4%) |